期刊
CELL REPORTS
卷 34, 期 2, 页码 -出版社
CELL PRESS
DOI: 10.1016/j.celrep.2020.108616
关键词
-
类别
资金
- NIH [R01DK118134, R01DK121178, R21AG063377, P30 AR066261]
- Services of the Harvard School of Dental Medicine Micro CT Core Facility
The study reveals that deficiency of KCTD1 leads to dysregulation of magnesium and calcium homeostasis, resulting in hypomagnesemia and hypocalcemia, subsequently causing secondary hyperparathyroidism and progressive metabolic bone disease. This is driven by the reduced expression of key transport proteins in the kidneys, impacting urinary reabsorption of magnesium and calcium.
Magnesium (Mg2+) homeostasis depends on active transcellular Mg2+ reuptake from urine in distal convoluted tubules (DCTs) via the Mg2+ channel TRPM6, whose activity has been proposed to be regulated by EGF. Calcium (Ca2+) homeostasis depends on paracellular reabsorption in the thick ascending limbs of Henle (TALs). KCTD1 promotes terminal differentiation of TALs/DCTs, but how its deficiency affects urinary Mg2+ and Ca2+ reabsorption is unknown. Here, this study shows that DCT1-specific KCTD1 inactivation leads to hypomagnesemia despite normal TRPM6 levels because of reduced levels of the sodium chloride co-transporter NCC, whereas Mg2+ homeostasis does not depend on EGF. Moreover, KCTD1 deficiency impairs paracellular urinary Ca2+ and Mg2+ reabsorption in TALs because of reduced NKCC2/claudin-16/-19 and increased claudin-14 expression, leading to hypocalcemia and consequently to secondary hyperparathyroidism and progressive metabolic bone disease. Thus, KCTD1 regulates urinary reabsorption of Mg2+ and Ca2+ by inducing expression of NCC in DCTs and NKCC2/claudin-16/-19 in TALs.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据